AGP Executive Report
Last update: 4 hours agoNative Health Care: Federal officials approved Utah’s Medicaid waiver to cover Native American traditional healing, citing potential benefits for mental health and chronic conditions. Utah is now among six states with Medicaid coverage for these practices. Utah Biotech: Salt Lake City’s Recursion says the FDA has agreed on the design of a Phase 3 trial for an experimental drug for familial adenomatous polyposis, a rare condition with no FDA-approved drug treatment. The trial is expected to start in late 2027. Measles Outbreak: The U.S. has lost its measles elimination status after more than a year of continuous spread. Utah has reported more than 700 cases in the current outbreak period, and a Utah pediatric infectious disease specialist warns cases may be undercounted. Health officials continue to urge MMR vaccination. Antibiotic Stewardship: Utah infectious disease doctors warn that antibiotics don’t treat viral colds and many respiratory infections, yet are prescribed for an estimated 30% to 50% of them. Unnecessary use can cause side effects and fuel drug resistance.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.